| Type | Article Title (sort by relevance) | Author(s) |
Date
|
Source | Cited By | |
|---|---|---|---|---|---|---|
| 1. | Articles | 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study |
|
Apr 2010 |
The Lancet Neurology,
|
8 |